Ruxandra Anton1, Mihail Ghenghea1, Violeta Ristoiu1, Christophe Gattlen2, Marc-Rene Suter2, Petre Alexandru Cojocaru3,4, Aurel Popa-Wagner4, Bogdan Catalin3,4, Alexandru-Florian Deftu1,2,5. 1. Department of Anatomy, Animal Physiology and Biophysics, Faculty of Biology, University of Bucharest, 050095 București, Romania. 2. Pain Center, Department of Anesthesiology, Lausanne University Hospital (CHUV) and Faculty of Biology and Medicine (FBM), University of Lausanne (UNIL), 1011 Lausanne, Switzerland. 3. Department of Physiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. 4. Experimental Research Center for Normal and Pathological Aging, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. 5. Earth, Environmental and Life Sciences Division, The Research Institute of the University of Bucharest (ICUB), 050107 București, Romania.
Abstract
(1) Background: As membrane channels contribute to different cell functions, understanding the underlying mechanisms becomes extremely important. A large number of neuronal channels have been investigated, however, less studied are the channels expressed in the glia population, particularly in microglia. In the present study, we focused on the function of the Kv1.3, Kv1.5 and Kir2.1 potassium channels expressed in both BV2 cells and primary microglia cultures, which may impact the cellular migration process. (2) Methods: Using an immunocytochemical approach, we were able to show the presence of the investigated channels in BV2 microglial cells, record their currents using a patch clamp and their role in cell migration using the scratch assay. The migration of the primary microglial cells in culture was assessed using cell culture inserts. (3) Results: By blocking each potassium channel, we showed that Kv1.3 and Kir2.1 but not Kv1.5 are essential for BV2 cell migration. Further, primary microglial cultures were obtained from a line of transgenic CX3CR1-eGFP mice that express fluorescent labeled microglia. The mice were subjected to a spared nerve injury model of pain and we found that microglia motility in an 8 µm insert was reduced 2 days after spared nerve injury (SNI) compared with sham conditions. Additional investigations showed a further impact on cell motility by specifically blocking Kv1.3 and Kir2.1 but not Kv1.5; (4) Conclusions: Our study highlights the importance of the Kv1.3 and Kir2.1 but not Kv1.5 potassium channels on microglia migration both in BV2 and primary cell cultures.
(1) Background: As membrane channels contribute to different cell functions, understanding the underlying mechanisms becomes extremely important. A large number of neuronal channels have been investigated, however, less studied are the channels expressed in the glia population, particularly in microglia. In the present study, we focused on the function of the Kv1.3, Kv1.5 and Kir2.1potassium channels expressed in both BV2 cells and primary microglia cultures, which may impact the cellular migration process. (2) Methods: Using an immunocytochemical approach, we were able to show the presence of the investigated channels in BV2 microglial cells, record their currents using a patch clamp and their role in cell migration using the scratch assay. The migration of the primary microglial cells in culture was assessed using cell culture inserts. (3) Results: By blocking each potassium channel, we showed that Kv1.3 and Kir2.1 but not Kv1.5 are essential for BV2 cell migration. Further, primary microglial cultures were obtained from a line of transgenicCX3CR1-eGFP mice that express fluorescent labeled microglia. The mice were subjected to a spared nerve injury model of pain and we found that microglia motility in an 8 µm insert was reduced 2 days after spared nerve injury (SNI) compared with sham conditions. Additional investigations showed a further impact on cell motility by specifically blocking Kv1.3 and Kir2.1 but not Kv1.5; (4) Conclusions: Our study highlights the importance of the Kv1.3 and Kir2.1 but not Kv1.5potassium channels on microglia migration both in BV2 and primary cell cultures.
Authors: A Bachmann; I Gutcher; K Kopp; J Brendel; R F Bosch; A E Busch; H Gögelein Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2001-11 Impact factor: 3.000
Authors: Philbert S Tsai; John P Kaufhold; Pablo Blinder; Beth Friedman; Patrick J Drew; Harvey J Karten; Patrick D Lyden; David Kleinfeld Journal: J Neurosci Date: 2009-11-18 Impact factor: 6.167
Authors: Oleg Butovsky; Mark P Jedrychowski; Craig S Moore; Ron Cialic; Amanda J Lanser; Galina Gabriely; Thomas Koeglsperger; Ben Dake; Pauline M Wu; Camille E Doykan; Zain Fanek; Liping Liu; Zhuoxun Chen; Jeffrey D Rothstein; Richard M Ransohoff; Steven P Gygi; Jack P Antel; Howard L Weiner Journal: Nat Neurosci Date: 2013-12-08 Impact factor: 24.884
Authors: Tae Hwan Shin; Da Yeon Lee; Yong Eun Jang; Do Hyeon Kwon; Ji Su Hwang; Seok Gi Kim; Chan Seo; Man Jeong Paik; Ju Yeon Lee; Jin Young Kim; Seokho Park; Sung-E Choi; Shaherin Basith; Myeong Ok Kim; Gwang Lee Journal: Cells Date: 2022-08-03 Impact factor: 7.666